Advertisement
Screener

Rapport Therapeutics, Inc. (RAPP) Market Cap

Rapport Therapeutics, Inc. (RAPP) Market Cap

  • 2026-09-03: Market Cap $2.28B.
  • 2026-08-03: Market Cap $1.96B.
  • 2026-06-30: Market Cap $2B.
  • 2026-05-04: Market Cap $1.7B.

Historical market capitalization from contemporaneous retained split-adjusted close and filed split-adjusted shares outstanding.

Available history
2024-06-30 to 2026-09-03
Data captured

Historical Market Cap

DateMarket Cap
2026-09-03$2.28B
2026-08-03$1.96B
2026-06-30$2B
2026-05-04$1.7B
2026-03-31$1.5B
2026-03-02$1.36B
2025-12-31$1.45B
2025-11-04$1.27B
2025-09-30$1.42B
2025-08-04$512.43M
2025-06-30$414.98M
2025-05-06$379.21M
2025-03-31$366.07M
2025-03-01$366.06M
2024-12-31$648.93M
2024-11-06$956.47M
2024-09-30$749.09M
2024-08-08$678.86M
2024-06-30$850.77M

Similar stocks

Stock NameCountryMarket CapPE Ratio
Stoke Therapeutics, Inc. (STOK)United States$1.630B-9.82
Xeris Biopharma Holdings, Inc. (XERS)United States$1.632B-80.10
Syndax Pharmaceuticals Inc (SNDX)United States$1.606B-8.82
Kailera Therapeutics, Inc. (KLRA)United States$1.552B
ANAPTYSBIO, INC (ANAB)United States$1.546B-60.20
Eton Pharmaceuticals, Inc. (ETON)United States$1.701B80.74
Innoviva, Inc. (INVA)United States$1.493B4.62
ArriVent BioPharma, Inc. (AVBP)United States$1.485B-10.25
Xencor Inc (XNCR)United States$1.776B-7.33
Septerna, Inc. (SEPN)United States$1.783B-63.01